The synthesis, characterization and antimicrobial activity determination of some aminopyridine-and (aminomethyl)pyridine-salicylaldimine copper(II) complexes were realized. The ligands, L 1-L 6 , were prepared by condensing salicylaldehyde and o-vanillin with 2-and 3-amino-and (aminomethyl)pyridine, respectively. The complexes were characterized by micro-analytical, electronic, infrared and conductivity data. The structures of the Schiff base ligands were further confirmed from 1 Hand 13 C-NMR spectral data. This study established that salicylaldimine ligands could coordinate as neutral species via the imine-N and the undeprotonated phenolic-O. The complexes have the molecular formula: [CuLCl], [Cu(LH) 2 Cl 2 ]•xH 2 O or [Cu(LH)Cl(H 2 O)]Cl. The X-ray crystal structure of [CuL 6 Cl] indicated a square planar geometry with the Schiff base ligand coordinated to the Cu(II) ion as a tridentate monobasic, N 2 O, ligand. The crystals crystallized in a monoclinic system with P2 1 /c space group. All the ligands and their Cu(II) complexes were screened for their antimicrobial activity against Staphylococcus aureus subsp. aureus ATCC ® 6538™ , Bacillus subtillis subsp. spizizenii ATCC ® 6633™ , Escherichia coli ATCC ® 8739™ and Candida albicans ATCC ® 2091™ using agar diffusion and broth dilution techniques. The presence of the methoxyl group enhanced the antimicrobial activity of the salicylaldimine Schiff base ligands.
Der potentiell dreizähnige Ligand N ,N,N ′,N ′‐Tetramethylpyridin‐2,6‐dicarboxamid, der durch Umsetzung von überschüssigem Dimethylamin mit Pyridin‐2,6‐dicarbonsäuredichlorid in Benzol in 80%iger Ausbeute entsteht, bildet mit Cu(II)‐chlorid den quadratisch‐pyramidalen Komplex (I).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.